Washington HB 1541: Addressing prescription drug cost transparency.

Status: By resolution, returned to House Rules Committee for third reading. (as of 2018-03-08)

State: Washington · Session: 2017-2018 · Bill: HB 1541

Subjects: INSURANCE, FINANCIAL MANAGEMENT, OFFICE, DRUGS

Sponsors: Robinson, Bergquist, Chapman, Clibborn, Cody, Doglio, Farrell, Fey, Fitzgibbon, Frame, Goodman, Gregerson, Harris, Hudgins, Jinkins, Johnson, Kagi, Kilduff, Lovick, Macri, McBride, Ormsby, Ortiz-Self, Orwall, Pellicciotti

View Washington HB 1541 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.